Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Laudadio · SciRah

Researcher profile · Semantic Scholar

L. Laudadio

Share profile

L. Laudadio — researcher profile on SciRah

h-index: 11
Works: 23
Citations: 601

Most-cited papers

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡
P. Conte, A. Frassoldati, G. Bisagni, A. Brandes +80 more
2018Annals of Oncology153 citations Open access
Semantic Scholar
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
N. Williams, A. Coppola, Buenos Aires, J. Itala +70 more
2007144 citations
Semantic Scholar
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
S. De Placido, C. Gallo, M. de Laurentiis, G. Bisagni +223 more
2018The Lancet Oncology77 citations Open access
Semantic Scholar
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
P. Vici, L. Pizzuti, A. Michelotti, I. Sperduti +44 more
2017OncoTarget61 citations Open access
Semantic Scholar
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
N. Tinari, C. Fanizza, M. Romero, E. Gambale +16 more
2015Clinical Breast Cancer39 citations Open access
Semantic Scholar
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer
L. di Lauro, P. Vici, P. del Medico, L. Laudadio +6 more
2013Breast Cancer Research and Treatment29 citations
Semantic Scholar
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience
L. Pizzuti, A. Giordano, A. Michelotti, M. Mazzotta +64 more
2018Journal of Cellular Physiology24 citations Open access
Semantic Scholar
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study
G. Arpino, A. Michelotti, M. Truini, F. Montemurro +17 more
2016Journal of Cancer Research and Clinical Oncology18 citations Open access
Semantic Scholar
Gemcitabine-induced posterior reversible encephalopathy syndrome: A case report
Pasquale Cioffi, L. Laudadio, A. Nuzzo, M. Belfiglio +2 more
2012Journal of Oncology Pharmacy Practice17 citations
Semantic Scholar
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
S. Gori, F. Puglisi, S. Moroso, A. Fabi +19 more
2019Clinical Breast Cancer16 citations Open access
Semantic Scholar
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer
S. Gori, A. Inno, E. Fiorio, J. Foglietta +32 more
2015PLoS ONE14 citations Open access
Semantic Scholar
Paralytic Ileus Associated with Capecitabine
L. Laudadio, E. Biondi, N. D'Ostilio, A. Cesta +3 more
2008Tumori4 citations
Semantic Scholar
Erratum: The promher study: An observational Italian study on adjuvant therapy for her2-positive, pt1a-b pn0 breast cancer stefania gori (PLoS ONE (2015) 10:9 (e0139650) DOI: 10.1371/journal.pone.0139650)
A. Inno, E. Fiorio, J. Foglietta, A. Ferro +31 more
20152 citations Open access
Semantic Scholar
Phase 3 randomized study of adjuvant anastrozole (A), exemestane (E), or letrozole (L) with or without tamoxifen (T) in postmenopausal women with hormone-responsive (HR) breast cancer: The FATA-GIM3 trial.
F. Perrone, C. Gallo, M. de Laurentiis, G. Bisagni +16 more
20171 citations
Semantic Scholar
F21Trastuzumab Emtansine (T-DM1) in Patients (pts) With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC): results From a Multicenter Retrospective Analysis
L. Pizzuti, I. Sperduti, A. Michelotti, C. Omarini +16 more
20161 citations Open access
Semantic Scholar
[Exclusive radical radiotherapy of laryngeal tumors: 10-year experience].
L. Basilico, M. Taraborrelli, L. Laudadio, A. Nuzzo +5 more
1997La Radiologia medica1 citations
Semantic Scholar
Journal of Cellular Physiology: Issue Information‐ToC
L. Pizzuti, A. Giordano, A. Michelotti, M. Mazzotta +61 more
2019Journal of Cellular Physiology0 citations Open access
Semantic Scholar
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer
S. Gori, A. Inno, E. Fiorio, J. Foglietta +32 more
2015PLoS ONE0 citations Open access
Semantic Scholar
Abstract P5-18-05: The Promher Study: An observational Italian study on HER2+ve, pT1a-b, pN0, M0 breast cancer (BC) patients (pts)
S. Gori, Monica Turazza, S. Duranti, E. Fiorio +27 more
20150 citations
Semantic Scholar
The reversible posterior leukoencephalopathy syndrome (RPLES) a case report of a new rare complication of gemcitabine
Pasquale Cioffi, L. Laudadio, C. Di Fabio, I. Grappasonni +2 more
20090 citations
Semantic Scholar
Paralytic ileus, a new rare toxicity of capecitabine: Two case reports
Pasquale Cioffi, L. Laudadio, I. Grappasonni, F. Petrelli +2 more
20080 citations
Semantic Scholar
Prevention of cisplatin-induced delayed emesis: still unsatisfactory
Q. Springer-Verlag, A. Nuzzo, L. Laudadio, S. C. B. Hospi +9 more
19990 citations
Semantic Scholar
[Clinical study of a new bronchodilator molecule in pediatrics (Th 1165, Fenoterol-Berotec)].
L. Longo, D. Patruno, A. Tempesta, O. Scaramuzzi +1 more
1981Minerva Pediatrica0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Vici×10
Invite
P. Vici — researcher profile on SciRah
S. Barni×9
Invite
S. Barni — researcher profile on SciRah
A. Nuzzo×8
Invite
A. Nuzzo — researcher profile on SciRah
L. Mentuccia×8
Invite
L. Mentuccia — researcher profile on SciRah

×8

Invite

T. Gamucci — researcher profile on SciRah

A. Frassoldati×7

Invite

A. Frassoldati — researcher profile on SciRah

Invite

G. Bisagni — researcher profile on SciRah

Invite

O. Garrone — researcher profile on SciRah

Invite

L. Cavanna — researcher profile on SciRah

Invite

A. Russo — researcher profile on SciRah

Invite

S. Gori — researcher profile on SciRah

Invite

D. Santini — researcher profile on SciRah